Stochastic agent-based modeling of infectious respiratory diseases with combined intervention strategies: A comprehensive framework for public health decision-making Stochastic ABM for disease control

Main Article Content

Fred Monari
https://orcid.org/0000-0002-3127-9310

Abstract

Traditional deterministic models for infectious diseases often overlook individual heterogeneity and stochastic events critical in outbreak dynamics. This study presents a comprehensive stochastic agent-based model to investigate the combined effects of face masks, quarantine, and vaccination on controlling respiratory diseases. The model simulates individual interactions in a population of 10,000 agents, capturing random transmission, intervention adherence variability, and complex contact patterns. Through extensive Monte Carlo simulations involving over 800 distinct scenario runs, we analyze outbreak probability, final epidemic size, peak prevalence, and intervention cost-effectiveness. Our results demonstrate that while combined interventions significantly reduce outbreak probability and scale, their effectiveness is highly sensitive to adherence levels and timing of implementation. The stochastic framework reveals substantial probabilities of major outbreaks even when the mean reproduction number is below unity, highlighting the critical importance of accounting for uncertainty in public health planning. Sensitivity analysis identifies contact rate and mask compliance as the most influential parameters, providing clear guidance for resource allocation. This approach provides crucial insights for designing robust, multi-layered intervention strategies that balance effectiveness with practical implementability in real-world settings.

Downloads

Download data is not yet available.

Article Details

How to Cite
[1]
Monari, F. 2026. Stochastic agent-based modeling of infectious respiratory diseases with combined intervention strategies: A comprehensive framework for public health decision-making: Stochastic ABM for disease control. Journal of Innovative Applied Mathematics and Computational Sciences. 6, 1 (Jul. 2026), 76–98. DOI:https://doi.org/10.58205/jiamcs.v6i1.1997.
Section
Research Articles

References

[1] H. M. Wᴀɴᴊᴀʟᴀ, M. O. Oᴋᴏɴɢᴏ and J. O. Oᴄʜᴡᴀᴄʜ, Mathematical Model of an Infectious Respiratory Disease with a Double-Dose Vaccine, Isolation and Use of Face-Mask, International Journal of Mathematical Sciences and Computing, 11(2) (2025), 1–15. https://doi.org/10.5815/ijmsc.2025.02.02

[2] S. F. Rᴀɪʟꜱʙᴀᴄᴋ and V. Gʀɪᴍᴍ, Agent-Based and Individual-Based Modeling: A Practical Introduction, Princeton University Press, Princeton, NJ, 2019. https://doi.org/10.2307/jj.28274141

[3] S. E. Eɪᴋᴇɴʙᴇʀʀʏ, M. Mᴀɴᴄᴜꜱᴏ, E. Iʙᴏɪ, T. Pʜᴀɴ, K. Eɪᴋᴇɴʙᴇʀʀʏ, Y. Kᴜᴀɴɢ, E. Kᴏꜱᴛᴇʟɪᴄʜ and A. B. Gᴜᴍᴇʟ, To mask or not to mask: Modeling the potential for face mask use by the general public to curtail the COVID-19 pandemic, Infectious Disease Modelling, 5 (2020), 293–308. https://doi.org/10.1016/j.idm.2020.04.001

[4] J. Wᴀʟʟɪɴɢᴀ and P. Tᴇᴜɴɪꜱ, Different epidemic curves for severe acute respiratory syndrome reveal similar impacts of control measures, American Journal of Epidemiology, 160(6) (2004), 509–516. https://doi.org/10.1093/aje/kwh255

[5] R. M. Aɴᴅᴇʀꜱᴏɴ and R. M. Mᴀʏ, Infectious Diseases of Humans: Dynamics and Control, Oxford University Press, Oxford, UK, 1991. https://doi.org/10.1002/hep.1840150131

[6] L. J. S. Aʟʟᴇɴ, A primer on stochastic epidemic models: Formulation, numerical simulation, and analysis, Infectious Disease Modelling, 2(2) (2017), 128–142. https://doi.org/10.1016/j.idm.2017.03.001

[7] M. E. J. Nᴇᴡᴍᴀɴ, Spread of epidemic disease on networks, Physical Review E, 66(1) (2002), 016128. https://doi.org/10.1103/physreve.66.016128

[8] P.-Y. Gᴇᴏꜰꜰᴀʀᴅ and T. Pʜɪʟɪᴘꜱᴏɴ, Rational epidemics and their public control, International Economic Review, 37(3) (1996), 603–624. https://doi.org/10.2307/2527443

[9] K. M. Bᴜʙᴀʀ, K. Rᴇɪɴʜᴏʟᴛ, S. M. Kɪꜱꜱʟᴇʀ, M. Lɪᴘꜱɪᴛᴄʜ, S. Cᴏʙᴇʏ, Y. H. Gʀᴀᴅ and D. B. Lᴀʀʀᴇᴍᴏʀᴇ, Model-informed COVID-19 vaccine prioritization strategies by age and serostatus, Science, 371(6532) (2021), 916–921. https://doi.org/10.1126/science.abe6959

[10] J. Hᴏᴡᴀʀᴅ, A. Hᴜᴀɴɢ, Z. Lɪ, Z. Tᴜꜰᴇᴋᴄɪ, V. Zᴅɪᴍᴀʟ, H.-M. ᴠᴀɴ ᴅᴇʀ Wᴇꜱᴛʜᴜɪᴢᴇɴ, A. ᴠᴏɴ Dᴇʟꜰᴛ, A. Pʀɪᴄᴇ, L. Fʀɪᴅᴍᴀɴ, L.-H. Tᴀɴɢ, V. Tᴀɴɢ, G. L. Wᴀᴛꜱᴏɴ, C. E. Bᴀx ᴇᴛ ᴀʟ., An evidence review of face masks against COVID-19, Proceedings of the National Academy of Sciences, 118(4) (2021), e2014564118. https://doi.org/10.1073/pnas.2014564118

[11] Q. Lɪ, X. Gᴜᴀɴ, P. Wᴜ, X. Wᴀɴɢ, L. Zʜᴏᴜ, Y. Tᴏɴɢ, R. Rᴇɴ, K. S. M. Lᴇᴜɴɢ, E. H. Y. Lᴀᴜ, J. Y. Wᴏɴɢ, X. Xɪɴɢ, N. Xɪᴀɴɢ, Y. Wᴜ ᴇᴛ ᴀʟ., Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia, New England Journal of Medicine, 382(13) (2020), 1199–1207. https://doi.org/10.1056/NEJMoa2001316

[12] S. A. Lᴀᴜᴇʀ, K. H. Gʀᴀɴᴛᴢ, Q. Bɪ, F. K. Jᴏɴᴇꜱ, Q. Zʜᴇɴɢ, H. R. Mᴇʀᴇᴅɪᴛʜ, A. S. Aᴢᴍᴀɴ, N. G. Rᴇɪᴄʜ and J. Lᴇꜱꜱʟᴇʀ, The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: Estimation and application, Annals of Internal Medicine, 172(9) (2020), 577–582. https://doi.org/10.7326/M20-0504

[13] D. P. Oʀᴀɴ and E. J. Tᴏᴘᴏʟ, Prevalence of asymptomatic SARS-CoV-2 infection: A narrative review, Annals of Internal Medicine, 173(5) (2020), 362–367. https://doi.org/10.7326/M20-3012

[14] F. P. Pᴏʟᴀᴄᴋ, S. J. Tʜᴏᴍᴀꜱ, N. Kɪᴛᴄʜɪɴ, J. Aʙꜱᴀʟᴏɴ, A. Gᴜʀᴛᴍᴀɴ, S. Lᴏᴄᴋʜᴀʀᴛ, J. L. Pᴇʀᴇᴢ, G. P. Mᴀʀᴄ, E. D. Mᴏʀᴇɪʀᴀ, C. Zᴇʀʙɪɴɪ, R. Bᴀɪʟᴇʏ, K. A. Sᴡᴀɴꜱᴏɴ, S. Rᴏʏᴄʜᴏᴜᴅʜᴜʀʏ ᴇᴛ ᴀʟ., Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine, New England Journal of Medicine, 383(27) (2020), 2603–2615. https://doi.org/10.1056/NEJMoa2034577

[15] M. H. Hᴀɪꜱᴄʜᴇʀ, R. Bᴇɪʟꜰᴜꜱꜱ, M. R. Hᴀʀᴛ, L. Oᴘɪᴇʟɪɴꜱᴋɪ, D. Wʀᴜᴄᴋᴇ, G. Zɪʀɢᴀɪᴛɪꜱ, T. D. Uʜʀɪᴄʜ and S. K. Hᴜɴᴛᴇʀ, Who is wearing a mask? Gender-, age-, and location-related differences during the COVID-19 pandemic, PLOS ONE, 15(10) (2020), e0240785. https://doi.org/10.1371/journal.pone.0240785

Similar Articles

<< < 1 2 3 > >> 

You may also start an advanced similarity search for this article.